I agree that this site is using cookies. You can find further informations here.
X
Sendur, H.N.
81  results:
Search for persons X
?
1

Quantitative ultrasound techniques and biochemical markers ..:

Coskun, M. ; Sendur, H. N. ; Babayeva, A....
Journal of Endocrinological Investigation.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Perianal fistula mapping at 3 T: volumetric versus conventi..:

Cerit, M.N. ; Öner, A.Y. ; Yıldız, A....
Clinical Radiology.  75 (2020)  7 - p. 563.e1-563.e9 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Associations between muscle elasticity in leg muscles and r..:

Cavusoglu, C. ; Sendur, H.N. ; Cerit, M.N....
Clinical Nutrition ESPEN.  40 (2020)  - p. 440 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Clinical characteristics, quality of life and risk factors ..:

Sarıkaya Solak, S. ; Kara Polat, A. ; Kilic, S....
Clinical and Experimental Dermatology.  47 (2021)  1 - p. 63-71 , 2021
Link: https://doi.org/10.1111/..
 
?
5

Localized monilethrix with improvement after treatment of i..:

Can Karaman, G ; Sendur, N ; Basar, H.
Journal of the European Academy of Dermatology and Venereology.  15 (2001)  4 - p. 362-364 , 2001
Link: https://doi.org/10.1046/..
 
?
6

Localized monilethrix with improvement after treatment of i..:

Can Karaman, G ; Sendur, N ; Basar, H.
Journal of the European Academy of Dermatology and Venereology.  15 (2001)  4 - p. 362-364 , 2001
Link: https://doi.org/10.1046/..
 
?
7

46P The frequency of driver mutations in non-small cell can..:

Yildirim, M.E. ; Cil, T. ; Artac, M....
ESMO Open.  9 (2024)  - p. 102625 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Amivantamab plus lazertinib versus osimertinib in first-lin..:

Felip, E. ; Cho, B.C. ; Gutiérrez, V....
Annals of Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
9

5MO Effect of amivantamab dose interruptions on efficacy an..:

García Campelo, M.R. ; Cho, B.C. ; Girard, N....
ESMO Open.  9 (2024)  - p. 102584 , 2024
Link: https://doi.org/10.1016/..
 
?
10

223P Real-world treatment efficacy of ribociclib or palboci..:

Kahraman, S. ; Erul, E. ; Gumusay, O....
ESMO Open.  9 (2024)  - p. 103245 , 2024
Link: https://doi.org/10.1016/..
 
?
11

LBA2 First-line (1L) durvalumab (D) + platinum-etoposide (E..:

Reinmuth, N. ; Özgüroğlu, M. ; Leighl, N.B....
Immuno-Oncology and Technology.  20 (2023)  - p. 100692 , 2023
Link: https://doi.org/10.1016/..
 
?
12

The effect of primary surgery in patients with stage IV bre..:

Soran, A. ; Dogan, L. ; Ozbas, S....
The Breast.  56 (2021)  - p. S68 , 2021
Link: https://doi.org/10.1016/..
 
?
13

3354 Prognostic factors for survival in patients with metas..:

Urun, Y. ; Abal, H. ; Turna, H....
European Journal of Cancer.  51 (2015)  - p. S686-S687 , 2015
Link: https://doi.org/10.1016/..
 
?
14

Schmerztherapeutische Bedarfsmedikation bei Attacken von fa..:

Giese, A. ; Örnek, A. ; Kurucay, M....
Der Schmerz.  27 (2013)  6 - p. 605-611 , 2013
Link: https://doi.org/10.1007/..
 
?
15

Clinical characteristics, quality of life and risk factors ..:

Solak, S. Sarikaya ; Polat, A. Kara ; Kilic, S...
Clinical And Experimental Dermatology.  , 2022
Link: https://hdl.handle.net/1..
 
1-15